Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.
about
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumorsMolecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancersTargeting bone physiology for the treatment of metastatic prostate cancerTargeting of alpha-v integrins reduces malignancy of bladder carcinomaMelatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.Cancer stem cells as a target population for drug discovery.Interactions between αv-Integrin and HER2 and Their Role in the Invasive Phenotype of Breast Cancer Cells In Vitro and in Rat Brain.Overexpressions of Vimentin and Integrins in Human Metastatic Spine Tumors.Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models.Regulation of integrin αV subunit expression by sulfatide in hepatocellular carcinoma cells.iTRAQ based quantitative proteomics approach validated the role of calcyclin binding protein (CacyBP) in promoting colorectal cancer metastasis.Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model.MicroRNA-92b represses invasion-metastasis cascade of esophageal squamous cell carcinoma.Sulfatide interacts with and activates integrin αVβ3 in human hepatocellular carcinoma cells.Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.The malignant social network: cell-cell adhesion and communication in cancer stem cellsRGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.Genetic variants in the integrin gene predicted microRNA-binding sites were associated with the risk of prostate cancer.The role of TWIST1 in epithelial-mesenchymal transition and cancers.Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.Induction of integrin α2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture.Prostate cancer cells home to bone using a novel in vivo model: modulation by the integrin antagonist GLPG0187.Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells.CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.miR-25, integrin and cancer invasiveness.Integrin signaling in cancer cell survival and chemoresistanceAbituzumab Targeting of αV-Class Integrins Inhibits Prostate Cancer Progression.High αv Integrin Level of Cancer Cells Is Associated with Development of Brain Metastasis in Athymic Rats.Integrin Signaling as a Cancer Drug Target
P2860
Q26786476-E7E9CE78-7A83-4569-8A5F-BD7609A3C79DQ26822406-D874E705-EC4F-4208-9AAA-B9B8ACAAA8F4Q26863249-41DD679B-9785-46C3-80A6-D7812569D41FQ28543173-B6356D4E-3D30-4A42-9C96-BED28DC3DAF5Q33624824-F05D717C-301E-4EA1-B9CE-59AD2415DD2EQ35238213-5A34755E-5EB5-4D81-91A3-26B8544385E8Q35390334-E1600922-D2DA-4B0C-83CF-232D7F60DEA4Q35724081-5F830520-873B-4192-A26A-F7D014D9477EQ35777800-F313BE99-91C1-422C-9487-5B786330F4C1Q36111439-1D7B1C09-5E83-40F9-85A8-A7AD88BAFFB2Q36709645-EB7CBB6A-7ACA-40BB-8D81-48B45E11BA99Q37001972-F4D541E6-F34F-4272-AEAF-05A2B19EFEDEQ37053185-5292B465-1DFB-4C33-AD04-EE6535A28545Q37190272-07C92D2E-C7C0-4534-929F-A8455C0FCFA6Q37392772-7EE7E355-A73E-43D5-BC0B-7C46B1599073Q37610799-50D95995-10AB-4323-A31E-6FE73511373BQ37615017-5201B1E9-2402-4509-AE36-9D888507A746Q37615286-2FD15C44-393F-4894-A57C-F0B008CEACD6Q37708926-79E575C6-74B0-4CCB-8182-CA5EAFC160E6Q38026421-AD865B24-E43F-4712-8084-09372D53C52EQ38161395-7AA4DB3C-607A-4E7F-9A49-2F17EDA673CAQ38320831-D72BB642-4751-484F-8487-FEE5340E56F7Q38646345-D3E7C0B1-F46B-468D-970F-8849A1AC01C3Q38945181-018E41AD-A778-453F-ABA6-DA2C57C1593CQ38958606-BFCE0FC4-18D5-43DC-8567-3EDAD68ADA8AQ38962837-B3820D7B-C366-4895-A991-34807AF2226EQ39446680-54157919-A7D2-4EB2-A516-50EE30AEFC90Q41459844-BE04C757-9914-4C3A-B563-8D633FB7F760Q41956753-3B6F2F10-F8CE-4B64-927F-4891018685DDQ42198719-DD6340A8-40D2-4311-A338-20E9C4FBBB79Q47099222-87F361B2-EC99-463C-B6CB-476A071A9B8CQ47817476-F326637F-F676-4A56-BACF-53C772282A56Q58992474-77D25014-058E-4A0C-A662-AD02A10F053C
P2860
Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Integrin αv expression is requ ...... type in human prostate cancer.
@ast
Integrin αv expression is requ ...... type in human prostate cancer.
@en
type
label
Integrin αv expression is requ ...... type in human prostate cancer.
@ast
Integrin αv expression is requ ...... type in human prostate cancer.
@en
prefLabel
Integrin αv expression is requ ...... type in human prostate cancer.
@ast
Integrin αv expression is requ ...... type in human prostate cancer.
@en
P2093
P2860
P1476
Integrin αv expression is requ ...... type in human prostate cancer.
@en
P2093
Christel van den Hoogen
Gabri van der Pluijm
Geertje van der Horst
Henry Cheung
Jeroen T Buijs
Rob C M Pelger
P2860
P304
P356
10.1016/J.AJPATH.2011.07.011
P407
P577
2011-09-09T00:00:00Z